Articles dans des revues avec comité de lecture (182)

  1. 74. Langer, I., Leroy, K., Gaspard, N., Brion, J. P., & Robberecht, P. (2008). Cell surface targeting of VPAC1 receptors: evidence for implication of a quality control system and the proteasome. Biochimica et biophysica acta, 1783(9), 1663-1672. doi:10.1016/j.bbamcr.2008.03.013
  2. 75. Brion, J. P. (2008). Biological models in frontotemporal dementias. Handbook of clinical neurology, 89, 449-455. doi:10.1016/S0072-9752(07)01241-9
  3. 76. Leroy, K., Bretteville, A., Schindowski, K., Gilissen, E., Authelet, M., De Decker, R., Yilmaz, Z., Buée, L., & Brion, J. P. (2007). Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice. The American journal of pathology, 171(3), 976-992. doi:10.2353/ajpath.2007.070345
  4. 77. Leroy, K., Yilmaz, Z., & Brion, J. P. (2007). Increased level of active GSK-3β in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration. Neuropathology and applied neurobiology, 33(1), 43-55. doi:10.1111/j.1365-2990.2006.00795.x
  5. 78. Pierrot, N., Santos, S. F., Feyt, C., Morel, M., Brion, J. P., & Octave, J. N. (2006). Calcium-mediated transient phosphorylation of tau and amyloid precursor protein followed by intraneuronal amyloid-beta accumulation. The Journal of biological chemistry, 281(52), 39907-39914. doi:10.1074/jbc.M606015200
  6. 79. Schindowski, K., Bretteville, A., Leroy, K., Bégard, S., Brion, J. P., Hamdane, M., & Buée, L. (2006). Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits. The American journal of pathology, 169(2), 599-616. doi:10.2353/ajpath.2006.060002
  7. 80. Brion, J. P. (2006). Immunological demonstration of tau protein in neurofibrillary tangles of Alzheimer's disease. Journal of Alzheimer's disease, 9(3 Suppl), 177-185.
  8. 81. Feyt, C., Kienlen-Campard, P. K., Leroy, K., N'Kuli, F., Courtoy, P., Brion, J. P., & Octave, J. N. (2005). Lithium chloride increases the production of amyloid-beta peptide independently from its inhibition of glycogen synthase kinase 3. The Journal of biological chemistry, 280(39), 33220-33227. doi:10.1074/jbc.M501610200
  9. 82. Derkinderen, P., Scales, T. M. E., Hanger, D., Leung, K.-Y., Byers, H. L., Ward, M. A., Lenz, C., Price, C., Bird, I. N., Perera, T., Kellie, S., Williamson, R., Noble, W., Van Etten, R. A., Leroy, K., Brion, J. P., Reynolds, C. H., & Anderton, B. (2005). Tyrosine 394 is phosphorylated in Alzheimer's paired helical filament tau and in fetal tau with c-Abl as the candidate tyrosine kinase. The Journal of neuroscience, 25(28), 6584-6593. doi:10.1523/JNEUROSCI.1487-05.2005
  10. 83. Debray, C., Vereecken, P., Belot, N., Teillard, P., Brion, J. P., Pandolfo, M., & Pochet, R. (2004). Multifaceted role of galectin-3 on human glioblastoma cell motility. Biochemical and biophysical research communications, 325(4), 1393-1398. doi:10.1016/j.bbrc.2004.10.181
  11. 84. Boutajangout, A., Authelet, M., Blanchard, V., Touchet, N., Tremp, G., Pradier, L., & Brion, J. P. (2004). Characterisation of cytoskeletal abnormalities in mice transgenic for wild-type human tau and familial Alzheimer's disease mutants of APP and presenilin-1. Neurobiology of disease, 15(1), 47-60. doi:10.1016/j.nbd.2003.09.007
  12. 85. Boutajangout, A., Boom, A., Leroy, K., & Brion, J. P. (2004). Expression of tau mRNA and soluble tau isoforms in affected and non-affected brain areas in Alzheimer's disease. FEBS letters, 576(1-2), 183-189. doi:10.1016/j.febslet.2004.09.011

  13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 Suivant >>